Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa

References

• Alving C. R. Delivery of liposome-encapsulated drugs to macrophages. Pharmacological Therapy 1983; 22: 407–424
   PubMed Web of Science ®Google Scholar
• Angus B. L., Carey A. M., Caron D. A., Kropinski A. M. B., Hancock R. E. W. Outer membrane permeability in Pseudomnas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrobial Agents in Chemotherapy 1982; 21: 299–309
   PubMed Web of Science ®Google Scholar
• Bangham A. D., Hill M. W., Miller N. G. A. Preparation and use of liposomes as models of biological membranes. Methods Membrane Biology 1974; 1: 1–68
   Google Scholar
• Bayer A. S., Peters J., Parr T. R., Jr, Chan L., Hancock R. E. W. Role of β-lactamase in in vivo development of ceftazidine resistance in an experimental Pseudomonas aeruginosa endocarditis model. Antimicrobial Agents Chemotherapy 1987; 31: 253–258
   PubMed Web of Science ®Google Scholar
• Bodey G. P., Bolivar R., Fainstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Review of Infectious Diseases 1983; 5(2)279–313
   PubMedGoogle Scholar
• Boyer A. S., Norman D. C., Kim K. S. Characterization of impermeability variants of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocardites. Antimicrobial Agents in Chemotherapy 1987; 31: 70–75
   PubMed Web of Science ®Google Scholar
• Bryan L. E., O'Hara K., Wong S. Lipopolysaccharides changes in impermeability-type aminoclycoside resistance in Pseudomonas aeruginosa. Antimicrobial Agents in Chemotherapy 1984; 26: 250–255
   PubMedGoogle Scholar
• Büscher K.-H., Cullman W., Dick W., Opferkuch W. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrobial Agents in Chemotherapy 1987; 31: 703–708
   PubMed Web of Science ®Google Scholar
• Caulcott C. A., Brown M. R. W., Gonda I. Evidence for small pores in the outer membrane of Pseudomonas aeruginosa. FEMS Microbiology Letters 1984; 21: 119–123
   Web of Science ®Google Scholar
• Clark R. B., Hu D. H., Janda J. M., Hostetter M. K. Increased susceptibility of gentamicin-resistant Pseudomonas aeruginosa to human sera. Current Microbiology 1986; 13: 159–162
   Web of Science ®Google Scholar
• Coune A. Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience. Infection 1988; 3: 141–147
   Google Scholar
• Cowan S. T. Cowan and Steel's Manual for the Identification of Medical Bacteria, 2nd edn. Cambridge University Press, Cambridge 1974
   Google Scholar
• Cystic Fibrosis Foundation. Pulmonary infection in cystic fibrosis. GAP Conference Report 1983; 7: 4
   Google Scholar
• Frère J.-M. Quantitative relationship between sensitivity to β-lactam antibiotics and β-lactamase production in gram-negative bacteria. I. Steady-state treatment. Biochemical Pharmacology 1989; 38: 1415–1426
   PubMed Web of Science ®Google Scholar
• Galbraith L., Wilkinson S. G., Legakis N. G., Genimata V., Katsorchis T. A., Rietschel E. T. Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa. Annals of Microbiology (Inst. Pasteur) 1984; 135B: 121–136
   Google Scholar
• Gilleland H. E., Jr. Adaptive alterations in the outer membrane of gram-negative bacteria during human infection. Canadian Journal of Microbiology 1988; 34: 499–502
   PubMed Web of Science ®Google Scholar
• Godfrey A. J., Bryan L. E., Rabin H. R. Beta-lactam resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrobial Agents Chemotherapy 1981; 19: 705–711
   PubMed Web of Science ®Google Scholar
• Godfrey A. J., Hatlelid L., Bryan L. E. Correlation between lipopolysaccharide structure and permeability resistance in β-lactam-resistant Pseudomonas aeruginosa. Antimicrobial Agents Chemotherapy 1984; 26: 181–186
   PubMed Web of Science ®Google Scholar
• Jorgensen J. H., Lee J. C., Alexander G. A. Rapid penicillinase paper strip test for detection of beta-lactamase producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrobial Agents Chemotherapy 1977; 11: 1087–1088
   PubMed Web of Science ®Google Scholar
• Kirby C., Gregoriadis G. Dehydration—rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology 1984; 2: 979–983
   Web of Science ®Google Scholar
• Lapointe J.-R., Faubert L. Détermination des α-carboxy-pénicillines chez le patient recevant une combinaison d'antibiotiques. Communication présentée au Congrès annuel 1982, Association de médecins microbiologistes du Québec, Val David, Québec, mai, 27–281982
   Google Scholar
• Livermore D. M. Do β-lactamases “trap” cephalosporins?. Journal of Antimicrobial Chemotherapy 1985; 15: 511–513
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Rosenblum M. G., Mehta R. Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. Cancer Drug Delivery 1984a; 1: 199–205
   PubMedGoogle Scholar
• Lopez-Berestein G., Hopfer R. L., Mehta R., Mehta K., Hersh E. M., Juliano R. L. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. Journal of Infectious Diseases 1984b; 150: 278–283
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Bodey G. P., Frankel L. S., Mehta K. Treatment of hepatosplenic candidiasis with liposomal amphotericin B. Journal of Clinical Oncology 1987; 5: 310–317
   PubMed Web of Science ®Google Scholar
• Lynch M. J., Drusano G. L., Mobley H. L. T. Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrobial Agents in Chemotherapy 1987; 31: 1892–1896
   PubMed Web of Science ®Google Scholar
• Nacucchio M. C., Gatto Bellora M. J., Sordelli D. O., D'Aquino M. Enhanced liposome-medicated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. Journal of Microencapsulation 1988; 5: 303–309
   PubMed Web of Science ®Google Scholar
• Nicas T. I., Hancock R. E. W. Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant. Journal of Bacteriology 1983; 153: 281–285
   PubMed Web of Science ®Google Scholar
• Nikaido H. Role of the outer membrane of gram-negative bacteria in antimicrobial resistance. Handbook of Experimental Pharmacology, Vol. 91, Microbial Resistance to Drugs, L. E. Bryan. Springer-Verlag KG, Berlin 1989; 1–34
   Google Scholar
• Nikaido H., Normark S. Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamases: a quantitative predictive treatment. Molecular Microbiology 1987; 1: 29–36
   PubMed Web of Science ®Google Scholar
• Olson B., Weinstein R. A., Nathan C., Chamberlin W., Kabins S. A. Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. Journal of Infectious Diseases 1985; 152: 769–774
   PubMed Web of Science ®Google Scholar
• Prince A. Antibiotic resistance of Pseudomonas species. Journal of Pediatrics 1986; 108(2)830–834
   PubMedGoogle Scholar
• Sanders C. C., Sanders W. E. Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Review of Infectious Diseases 1983; 5: 639–648
   PubMedGoogle Scholar
• Sanders C. C., Sanders W. E. Microbial resistance to newer generation β-lactam antibiotics: clinical and laboratory implications. Journal of Infectious Diseases 1985; 151: 399–406
   PubMed Web of Science ®Google Scholar
• Sawai T., Matsuba K., Yamagishi S. A method for measuring the outer membrane permeability of β-lactam antibiotics in gram-negative bacteria. Journal of Antibiotics 1977; 30: 1134–1136
   PubMed Web of Science ®Google Scholar
• Stratton C. W., Tausk F. Synergistic resistance mechanisms in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1987; 19: 413–416
   PubMed Web of Science ®Google Scholar
• Szoka F. C., Papahadjopoulos D. A new procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences, U.S.A. 1978; 75: 4194–4198
   PubMed Web of Science ®Google Scholar
• Takakuma T., Ikewaki N., Yasuda T., Tsutsumi M., Saito S., Saito K. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Antimicrobial Agents in Chemotherapy 1985; 28: 28–32
   PubMed Web of Science ®Google Scholar
• Trias J., Dufresne J., Lévesque R. C., Nikaido H. Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrobial Agents in Chemotherapy 1989; 33(8)1201–1206
   Web of Science ®Google Scholar
• Yoneyama H., Akatsuka A., Nakae T. The outer membrane of Pseudomonas aeruginosa is a barrier against the penetration of disaccharides. Biochemical and Biophysical Research Communications 1986; 134: 106–112
   PubMed Web of Science ®Google Scholar
• Yoshimura F., Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. Journal of Bacteriology 1982; 152: 636–642
   PubMed Web of Science ®Google Scholar
• Zak O. Antibiotics and Pseudomonas aeruginosa—The organism, diseases it causes, and their treatment, L. D. Sabath. Hans Huber Publishers, BernSwitzerland 1980; 133–159
   Google Scholar